JPRN-UMIN000021708招募中未知
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene. - A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.
Department of Nephrology and Endocrinology, The University of Tokyo Hospital0 个研究点目标入组 3 人开始时间: 2016年4月18日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 3
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) History of allergy to tolvaptan 2) Pregnant women and women suspected of being pregnant 3) Severe Renaldysfunction (eGFR < 30 mL/min/1.73m2) 4) Severe liver dysfunction (AST > 100 U/L or ALT > 100 U/L) 5) Congestive heart failure 6) Active TBc 7) Substance use disorder 8) Use of investigational drug within 4 months before participation of this study 9) Amount of whole blood sampling > 200 mL within 4 weeks, amount of whole blood sampling > 400 mL within 12 weeks, or plasmapheresis / platelet apheresis within 2 weeks. 10) Doctor's decision
研究者
相似试验
尚未招募
4 期
A study on the safety and efficasy of tolvaptan for patients with fluid retention after cardiothoracic surgeryPatients received cardiothoracic surgery with congestive heart failure.JPRN-UMIN000011172Osaka city university graduate school of medicine210
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119
已完成
不适用
Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertensiopulmonary hypertensionJPRN-UMIN000010196Department of Cardiology, Keio University School of Medicine40
已完成
4 期
A study on the safety and effectiveness of tolvaptan for patients with fluid retention after valvular surgeryJPRN-UMIN000009957Osaka University Graduate School of Medicine100
已完成
4 期
Clinical Efficacy Study of Tolvaptan on Patients with Autosomal Dominant Polycystic Kidney DiseaseAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000015715Kyorin University School of Medicine100